HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice. (Q48430846)

11 February 2018

title

HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice. (English)

1 reference

11 February 2018

1 reference

1 reference

Veljko Puskovic

1

1 reference

11 February 2018

Darren Wolfe

2

1 reference

11 February 2018

James Wechuck

3

1 reference

11 February 2018

David Krisky

4

1 reference

11 February 2018

Jeff Collins

5

1 reference

11 February 2018

Joseph C Glorioso

6

1 reference

11 February 2018

David J Fink

7

1 reference

11 February 2018

Marina Mata

8

1 reference

11 February 2018

publication date

1 September 2006

1 reference

11 February 2018

published in

Molecular Therapy

1 reference

11 February 2018

volume

14

1 reference

11 February 2018

page(s)

710-715

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

In vivo evidence that erythropoietin protects neurons from ischemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Erythropoietin both protects from and reverses experimental diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Localization of specific erythropoietin binding sites in defined areas of the mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Ischemic tolerance and endogenous neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Localized striatal delivery of GDNF as a treatment for Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Emerging biological roles for erythropoietin in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Expectations and challenges in the therapeutic use of neurotrophic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.07.004

10.1016/J.YMTHE.2006.07.004

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

16949343

1 reference

11 February 2018